| Dr Michele Imogene Hensley, MD | |
|
1125 Carthage St, Sanford, NC 27330-4162 | |
| (919) 774-6023 | |
| (919) 776-6359 |
| Full Name | Dr Michele Imogene Hensley |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 42 Years |
| Location | 1125 Carthage St, Sanford, North Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497830822 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 9500094 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Central Carolina Hospital | Sanford, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dlp Central Carolina Medical Group Llc | 3577840420 | 28 |
News Archive
New data presented at the American Thoracic Society's 2004 International Conference show that once-daily treatment with the investigational therapy Alvesco (ciclesonide) in mild-to-moderate asthma patients has no effect on normal adrenal function, as demonstrated by measurements of the hypothalamic-pituitary-adrenal (HPA)-axis.
It sounds like a late-night commercial: In just one hour you can reduce your anxiety levels and some heart health risk factors. But a recent study with 14 participants shows preliminary data that even a single session of meditation can have cardiovascular and psychological benefits for adults with mild to moderate anxiety.
Keryx Biopharmaceuticals, Inc. today announced that abstract O-0017, entitled "Subset Analysis of 5-FU Refractory Patients from a Randomized Ph II Study of Perifosine + Capecitabine (P-CAP) vs. Placebo + Capecitabine (CAP) in Patients with 2nd or 3rd Line Metastatic CRC" has been selected for oral presentation at the upcoming 12th World Congress on Gastrointestinal Cancer, to be held in Barcelona, Spain from June 30 - July 2, 2010.
A survey indicates that research is active and diverse at U.S. academic medical centers and that a substantial proportion of faculty conduct research and publish without sponsorship, according to a study in the September 2 issue of JAMA.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Doxycycline Hyclate Delayed-release (DR) Tablets USP, 150 mg. This product is the generic version of Mayne Pharma's Doryx, which is a tetracycline-class antimicrobial.
› Verified 5 days ago
| Entity Name | Dlp Central Carolina Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184163883 PECOS PAC ID: 3577840420 Enrollment ID: O20170503000867 |
News Archive
New data presented at the American Thoracic Society's 2004 International Conference show that once-daily treatment with the investigational therapy Alvesco (ciclesonide) in mild-to-moderate asthma patients has no effect on normal adrenal function, as demonstrated by measurements of the hypothalamic-pituitary-adrenal (HPA)-axis.
It sounds like a late-night commercial: In just one hour you can reduce your anxiety levels and some heart health risk factors. But a recent study with 14 participants shows preliminary data that even a single session of meditation can have cardiovascular and psychological benefits for adults with mild to moderate anxiety.
Keryx Biopharmaceuticals, Inc. today announced that abstract O-0017, entitled "Subset Analysis of 5-FU Refractory Patients from a Randomized Ph II Study of Perifosine + Capecitabine (P-CAP) vs. Placebo + Capecitabine (CAP) in Patients with 2nd or 3rd Line Metastatic CRC" has been selected for oral presentation at the upcoming 12th World Congress on Gastrointestinal Cancer, to be held in Barcelona, Spain from June 30 - July 2, 2010.
A survey indicates that research is active and diverse at U.S. academic medical centers and that a substantial proportion of faculty conduct research and publish without sponsorship, according to a study in the September 2 issue of JAMA.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Doxycycline Hyclate Delayed-release (DR) Tablets USP, 150 mg. This product is the generic version of Mayne Pharma's Doryx, which is a tetracycline-class antimicrobial.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michele Imogene Hensley, MD 2510 Greenway Ave, Raleigh, NC 27608-1308 Ph: (919) 789-9800 | Dr Michele Imogene Hensley, MD 1125 Carthage St, Sanford, NC 27330-4162 Ph: (919) 774-6023 |
News Archive
New data presented at the American Thoracic Society's 2004 International Conference show that once-daily treatment with the investigational therapy Alvesco (ciclesonide) in mild-to-moderate asthma patients has no effect on normal adrenal function, as demonstrated by measurements of the hypothalamic-pituitary-adrenal (HPA)-axis.
It sounds like a late-night commercial: In just one hour you can reduce your anxiety levels and some heart health risk factors. But a recent study with 14 participants shows preliminary data that even a single session of meditation can have cardiovascular and psychological benefits for adults with mild to moderate anxiety.
Keryx Biopharmaceuticals, Inc. today announced that abstract O-0017, entitled "Subset Analysis of 5-FU Refractory Patients from a Randomized Ph II Study of Perifosine + Capecitabine (P-CAP) vs. Placebo + Capecitabine (CAP) in Patients with 2nd or 3rd Line Metastatic CRC" has been selected for oral presentation at the upcoming 12th World Congress on Gastrointestinal Cancer, to be held in Barcelona, Spain from June 30 - July 2, 2010.
A survey indicates that research is active and diverse at U.S. academic medical centers and that a substantial proportion of faculty conduct research and publish without sponsorship, according to a study in the September 2 issue of JAMA.
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Doxycycline Hyclate Delayed-release (DR) Tablets USP, 150 mg. This product is the generic version of Mayne Pharma's Doryx, which is a tetracycline-class antimicrobial.
› Verified 5 days ago
Hiromi Maruyama, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2412 Wilkins Dr, Sanford, NC 27330 Phone: 919-776-6000 | |
Francesco Robert Olivito, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 4546 Nc Highway 87 South, Sanford, NC 27332 Phone: 919-499-5151 Fax: 919-499-5147 | |
Dr. Robert Howard Mcconville Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1125 Carthage St, Sanford, NC 27330 Phone: 919-774-6023 Fax: 919-776-6359 | |
Dr. William E. Hall, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 219 Maple Ave, Sanford, NC 27330 Phone: 919-770-9102 Fax: 919-775-3377 | |
Daniel Paul Woydick, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1125 Carthage St, Sanford, NC 27330 Phone: 919-774-6023 Fax: 919-776-6359 | |
Schuyler Karl Behnke, PA-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 125 Chatham Street, Sanford, NC 27330 Phone: 919-775-1115 Fax: 919-775-1113 | |
Daphne Joan Cates, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2412 Wilkins Dr, Sanford, NC 27330 Phone: 919-776-6000 Fax: 919-776-0130 |